CLDI

0.47755.45%
SL

Scott Leftwich

Independent Vice-Chairman of the Board

Mr. Scott Leftwich serves as an Independent Vice-Chairman of the Board at Calidi Biotherapeutics, Inc. since May 2019. Since 2017 Mr. Leftwich has been an Investor and Member of the Board of Advisors at Skopos Labs, Inc. He was Senior Vice President of Equifax Technology and Analytical Services Division at Anakam, Inc. Mr. Leftwich served as General Manager Anakam for Equifax Technology and Analytical Services Division of Anakam, Inc. From December 2011 to April 2016, Mr. Leftwich was the CEO and General Manager at InterMedHx, LLC. He has operational leadership experience to Anakam. He has been instrumental in the hiring of the senior management team and the successful execution of operations for Anakam, Inc. Mr. Leftwich served as the Chief Operating Officer of Anakam, Inc. since September 2005 to December 2011. Mr. Leftwich was responsible for supporting the Chief Executive Officer in the successful execution of operations for the Anakam. He has served as the Chief Operating Officer of three separate companies, including a very successful government services firm in which he personally hired most of the senior staff and helped build the systems. Prior to the commercial business world, Mr. Leftwich was a US Navy pilot who deployed all over the world flying the P-3C anti-submarine warfare aircraft. When not deployed, he served as an Analyst for both the Comptroller of the Navy and the Director of Program Appraisal and as the military assistant to the Assistant Secretary of Defense for Legislative Affairs. Commander Leftwich's final tour in the Navy was in the White House Military Office where he was a program Manager directing emergency planning efforts in support of the President. Mr. Leftwich graduated seventh in his class at the United States Naval Academy. He holds an MBA with honors from Harvard Business School, in addition to a BS with distinction from the US Naval Academy.

Positions